Cargando…
P1225: SECONDARY PRIMARY MALIGNANCIES (SPM) AFTER HIGH-DOSE CHEMOTHERAPY (HDT) WITH AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR LYMPHOMA: A DANISH NATIONWIDE COHORT STUDY
Autores principales: | Trab, T., Baech, J., Hjort Jakobsen, L., Husby, S., Tang Severinsen, M., Eloranta, S., Gørløv, J. S., Jørgensen, J. M., Gudbrandsdottir, S., Stauffer Larsen, T., Brown, P., Smedby, K. E., Christoffer El-Galaly, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430672/ http://dx.doi.org/10.1097/01.HS9.0000847764.17058.3f |
Ejemplares similares
-
P081: Treatment-related circulatory diseases and mortality in Hodgkin lymphoma patients using multi-state modelling and relative survival
por: Baech, Joachim, et al.
Publicado: (2022) -
A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatment
por: Jensen, Paw, et al.
Publicado: (2022) -
PB2706: NO DIFFERENCE IN SURVIVAL OUTCOMES BETWEEN IMMIGRANTS AND DANISH-BORN CITIZENS WITH A HEMATOLOGICAL MALIGNANCY: A NATIONWIDE, POPULATION-BASED REGISTER STUDY
por: Baech, Joachim, et al.
Publicado: (2023) -
Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy
por: Baech, Joachim, et al.
Publicado: (2022) -
Work Disability and Return to Work After Lymphoma: A Danish Nationwide Cohort Study
por: Maksten, Eva Futtrup, et al.
Publicado: (2023)